713-928-2355
Menu
  • Home
  • Practice Areas
    • Personal Injury and Dangerous Devices
      • Philips® CPAP Recall
      • Knee Implant Failure
      • Elbow Implant Failure
      • Shoulder Replacement Lawsuit
      • 3M Earplug Lawsuit
    • Drug Injury
      • Purdue Opioid Claim
      • Invokana © and other SGLT2 Drugs Risk of Fournier Gangrene
      • Invokana® Increased Risk of Leg and Foot Amputations
      • Shingles Vaccine Lawsuit Zostavax®
    • Birth Injury
      • Depakote®
      • Dilantin®
      • Paxil®
      • Zofran®
      • Zoloft®
  • Maritime Injury
  • Buffalo Bayou or SJ River Claim
  • About
    • Victor Longo
  • Testimonials
  • Blog
  • Contact Us
Home / Uncategorized / Fosamax® Bone Fractures

Fosamax® Bone Fractures

  • Home

While Fosamax® may be effective in the short term for treating osteoporosis, Fosamax® and other bisphosphonates with extended usage may actually decrease the strength of bones, particularly the femur.
 
The U.S. Food and Drug Administration (FDA) has updated the public describing the risk of atypical fractures of the thigh for those taking bisphosphonates for osteoporosis. The FDA is now requiring the Warnings and Precautions section of the labels be updated of all bisphosphonate drugs approved for the prevention or treatment of osteoporosis. FDA is also requiring a new Limitations of Use statement in the Indications and Usage section of the labels for these drugs. This is intended to provide information to the consumer that there is uncertainty as to the optimal duration of use of bisphosphonates for osteoporosis.

While Fosamax® and other osteoporosis drugs are supposed to prevent or slow the loss of bone mass, long-term use may increase the risk of certain fractures. Often these fractures can occur while doing relatively low impact activities. Further, a serious condition called “dead jaw” or osteonecrosis may be associated with bisphosphonate drugs. The FDA listed the bisphosphonates affected by the notice as Fosamax®, Fosamax Plus D®, Actonel®, Actonel with Calcium®, Boniva®, Atelvia®, and Reclast®.

Any of these conditions is serious and painful. Hospitalization and/or surgery may be needed. If you or a loved has osteonecrosis of the jaw or femur fracture and took a bisphosphonate, please call us to get more information.

Source: FDA Drug Safety Communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures, 10-13-2010.

LikeBox

Phone: 713-928-2355
Fax: 1-713-923-1043
5728 Hood Street
Houston, TX 77023
Disclaimer/Warning This site is a public resource for general information. Nothing in this website should be considered legal advice. Communications by you through this website do not establish an attorney-client relationship. Our professional obligations require that before accepting any new client, we must determine whether any conflicts exist with current or former clients. To inquire about legal representation, please call or email us. An attorney-client relationship will not be created by placing a call or sending an email. Any medical decision is important. You should not stop taking any prescribed medication unless advised to do so by your doctor. Consult your doctor before making any medical decision and do not rely upon this website in making any medical decision. Attorney licensed in Texas. Attorney not certified by the Boards of Legal Specialization in any state. Not all states have board certifications. Attorney Victor Longo is responsible for the content of this advertisement. Representation is not available in all states and Longo Legal, PLLC is not accepting cases in all states. Longo Legal, PLLC may associate with other law firms in other states and jurisdictions as required. Cases will likely be referred to other lawyers for handling. © Copyright 2016 Longo Legal